IBDEI0PV ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11628,2)
 ;;=^5002735
 ;;^UTILITY(U,$J,358.3,11629,0)
 ;;=I15.8^^46^563^18
 ;;^UTILITY(U,$J,358.3,11629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11629,1,3,0)
 ;;=3^Secondary Hypertension,Other
 ;;^UTILITY(U,$J,358.3,11629,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,11629,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,11630,0)
 ;;=E27.5^^46^563^1
 ;;^UTILITY(U,$J,358.3,11630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11630,1,3,0)
 ;;=3^Adrenomedullary Hyperfunction
 ;;^UTILITY(U,$J,358.3,11630,1,4,0)
 ;;=4^E27.5
 ;;^UTILITY(U,$J,358.3,11630,2)
 ;;=^5002744
 ;;^UTILITY(U,$J,358.3,11631,0)
 ;;=E26.01^^46^563^4
 ;;^UTILITY(U,$J,358.3,11631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11631,1,3,0)
 ;;=3^Conn's Syndrome
 ;;^UTILITY(U,$J,358.3,11631,1,4,0)
 ;;=4^E26.01
 ;;^UTILITY(U,$J,358.3,11631,2)
 ;;=^329905
 ;;^UTILITY(U,$J,358.3,11632,0)
 ;;=I15.9^^46^563^19
 ;;^UTILITY(U,$J,358.3,11632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11632,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,11632,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,11632,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,11633,0)
 ;;=B20.^^46^564^3
 ;;^UTILITY(U,$J,358.3,11633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11633,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,11633,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,11633,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,11634,0)
 ;;=J18.9^^46^564^6
 ;;^UTILITY(U,$J,358.3,11634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11634,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,11634,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,11634,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,11635,0)
 ;;=J10.1^^46^564^1
 ;;^UTILITY(U,$J,358.3,11635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11635,1,3,0)
 ;;=3^Flu w/ Respiratory Manifestations
 ;;^UTILITY(U,$J,358.3,11635,1,4,0)
 ;;=4^J10.1
 ;;^UTILITY(U,$J,358.3,11635,2)
 ;;=^5008151
 ;;^UTILITY(U,$J,358.3,11636,0)
 ;;=K52.9^^46^564^2
 ;;^UTILITY(U,$J,358.3,11636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11636,1,3,0)
 ;;=3^Gastroenteritis & Colitis,Noninfective,Unspec
 ;;^UTILITY(U,$J,358.3,11636,1,4,0)
 ;;=4^K52.9
 ;;^UTILITY(U,$J,358.3,11636,2)
 ;;=^5008704
 ;;^UTILITY(U,$J,358.3,11637,0)
 ;;=N12.^^46^564^7
 ;;^UTILITY(U,$J,358.3,11637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11637,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,11637,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,11637,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,11638,0)
 ;;=L97.509^^46^564^4
 ;;^UTILITY(U,$J,358.3,11638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11638,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer Unspec Foot w/ Unspec Severity
 ;;^UTILITY(U,$J,358.3,11638,1,4,0)
 ;;=4^L97.509
 ;;^UTILITY(U,$J,358.3,11638,2)
 ;;=^5009544
 ;;^UTILITY(U,$J,358.3,11639,0)
 ;;=M86.10^^46^564^5
 ;;^UTILITY(U,$J,358.3,11639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11639,1,3,0)
 ;;=3^Osteomylitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,11639,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,11639,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,11640,0)
 ;;=E85.9^^46^565^1
 ;;^UTILITY(U,$J,358.3,11640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11640,1,3,0)
 ;;=3^Amyloidosis,Unspec
 ;;^UTILITY(U,$J,358.3,11640,1,4,0)
 ;;=4^E85.9
 ;;^UTILITY(U,$J,358.3,11640,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,11641,0)
 ;;=N00.9^^46^565^3
 ;;^UTILITY(U,$J,358.3,11641,1,0)
 ;;=^358.31IA^4^2
